URAC Disease Management Accreditation — Frequently Asked Questions

Last updated: April 2026

IHS has guided health plans, disease management organizations, and population health vendors through URAC Disease Management Accreditation for over 25 years. These answers reflect the questions we hear most often — and the places where organizations most frequently encounter difficulty. If your question is not answered here, schedule a free consultation with an IHS principal.

What is URAC Disease Management Accreditation?

URAC Disease Management Accreditation is a quality credential from the Utilization Review Accreditation Commission recognizing organizations that demonstrate structured, evidence-based management of defined populations living with chronic conditions and co-morbidities. It validates an organization's patient communication model, risk stratification approach, quality management infrastructure, consumer engagement strategies, and provider collaboration — all oriented toward slowing disease progression and reducing preventable utilization.

Seventy-five percent of Americans live with at least one chronic condition, and fifty percent carry multiple conditions. The accreditation exists because managing that burden effectively at scale requires a documented, measurable, independently verified approach — not just well-intentioned programming.

Who is eligible for URAC Disease Management Accreditation?

Any organization managing a defined population with chronic disease or co-morbid conditions operating in the United States is eligible. This includes:

• Health plans — HMOs, PPOs, and integrated managed care organizations running in-house DM programs
• Standalone disease management companies contracting with health plans, employers, or government programs
• Population health management vendors and organizations
• Health systems and integrated delivery networks with structured DM programs for their patient population
• Employer-sponsored health program administrators managing chronic conditions for self-insured groups

The key eligibility criterion is active management of a defined population — not simply offering disease-related educational resources or wellness programs.

What does URAC Disease Management Accreditation cover?

URAC Disease Management standards address four core functional domains:

• Patient communication and education — multi-format, health-literacy-appropriate communications individualized to the managed population and specific conditions
• Risk management oversight — structured population identification, risk stratification, escalation protocols, and documented responses to identified risks
• Quality management infrastructure — QI program structure, performance measurement, outcome tracking, and demonstrated continuous improvement activity with a required operational history
• Consumer engagement strategies — shared decision-making support, self-management tools, behavioral change approaches, and measurement of engagement effectiveness

Provider collaboration — how the DM organization communicates with treating clinicians and avoids duplication — is woven throughout the standards rather than isolated in a single module.

How is URAC Disease Management Accreditation different from URAC Case Management Accreditation?

Disease Management Accreditation addresses population-level management of chronic conditions — how an organization identifies, stratifies, engages, and monitors outcomes across an entire defined population. Case Management Accreditation addresses individual-level coordination of care — how an organization manages specific patients through complex care episodes with individualized assessments, care plans, and documented case closure.

Organizations often need both. A health plan or DM company may run a DM program for its entire chronically ill population while also providing intensive individual case management for the highest-complexity members of that population. IHS can help determine which credentials your operational scope requires.

Is URAC Disease Management Accreditation voluntary or required?

URAC accreditation is voluntary at the federal level. However, it is frequently required or strongly preferred by:

• Commercial health plan client contracts — many health plans require their DM vendors to hold URAC accreditation
• State Medicaid managed care procurement specifications
• Employer group RFP requirements for disease management vendors
• Government program participation criteria

In practice, for disease management companies selling to health plans or competing in government procurement markets, URAC Disease Management Accreditation is functionally mandatory in many market segments — even when it is not technically required by law.

How long does URAC Disease Management Accreditation take?

Plan for 10 to 14 months from initial consulting engagement to accreditation decision. URAC markets a shorter process, but this does not account for the look-back period requirement — organizations must demonstrate that their procedures were operationally in place before the survey, not just recently documented.

A realistic milestone timeline:

• Weeks 1–6: Gap analysis and Standard-by-Standard Review
• Months 2–5: Policy, procedure, and quality management infrastructure development
• Months 3–8: Look-back period accumulation (concurrent with development)
• Months 8–9: Mock survey and final gap closure
• Month 9–10: AccreditNet submission
• Months 10–12: URAC desktop review and RFI response (if issued)
• Months 12–14: Validation review and accreditation determination

Organizations with mature existing quality systems may compress this timeline. Organizations starting from a low baseline should plan for the longer end.

What is the look-back period for URAC Disease Management Accreditation?

The look-back period is the span of operational history URAC reviewers assess to confirm that documented policies were actually being followed before the survey — not just implemented in the weeks prior. It varies by standard but generally spans three to twelve months of demonstrated practice.

This is the single most underestimated requirement in URAC accreditation. Organizations that implement policies in response to a gap analysis but do not build operational evidence over time consistently fail standards they believed they satisfied. IHS incorporates look-back period strategy from the first day of every engagement.

What are the most common reasons organizations fail URAC Disease Management Accreditation?

• Look-back period failures — policies adopted too close to the survey date with no operational history
• Non-individualized patient communications — generic educational materials that do not address specific populations or health literacy levels
• Risk stratification gaps — inability to document how the organization identifies high-risk individuals and manages them differently from lower-risk members
• Quality management infrastructure on paper only — QI program documents that exist but lack demonstrated operational history or measurable improvement activity
• Consumer engagement documentation describing intent rather than activity — policies about what the organization will do rather than evidence of what it has done
• Inadequate provider collaboration evidence — no documented process for coordinating with treating clinicians or avoiding duplication of care management activities

How much does URAC Disease Management Accreditation cost?

URAC fees are customized based on organizational size, operational scope, and the specific accreditation modules selected. Fees are not publicly disclosed by URAC and are non-refundable if accreditation is denied.

IHS consulting engagements are scoped per engagement. Contact IHS to discuss your organization's current state and receive a tailored proposal.

What is the URAC accreditation process from start to finish?

The URAC Disease Management Accreditation process follows these phases:

1. Obtain current standards and conduct a gap analysis against existing documentation and operations
2. Consult with an accreditation consulting firm to map requirements to your operational context
3. Sign the URAC application agreement
4. Develop and implement compliant policies, procedures, and quality management systems
5. Accumulate the required look-back period of operational evidence
6. Submit documentation through URAC's AccreditNet portal
7. Undergo URAC desktop review — reviewer may issue an RFI requesting additional information
8. Complete the validation review — on-site or remote interview of staff and documentation
9. Receive the accreditation determination

What is a URAC RFI and how does it affect Disease Management Accreditation?

A URAC Request for Information is issued after desktop review when the reviewer requires additional documentation, clarification, or evidence to score a standard. An RFI is not a denial — it is a formal request for what was missing or ambiguous in the initial submission.

RFI responses must be precisely responsive to the specific deficiency identified by the reviewer. Organizations that do not understand the standard at issue frequently provide responses that do not resolve the concern — resulting in a finding against the standard. IHS has extensive experience drafting RFI responses that address reviewer findings with the precision the process requires.

Can a disease management organization pursue URAC accreditation without a consultant?

Yes. URAC accreditation does not require a consultant, and URAC notes that using a consultant does not guarantee accreditation. Organizations that navigate the process without guidance, however, frequently underestimate look-back period requirements, misinterpret standard language, submit incomplete documentation, and require time-consuming resubmissions. The most common outcome for unassisted first-time applicants is delay rather than outright denial — but delay in an accreditation-dependent contracting environment has real costs.

A specialized firm with direct URAC institutional knowledge materially reduces the probability of delay and resubmission.

What is a mock survey and why does it matter?

A mock survey is a pre-submission simulation of the URAC validation review process — an experienced consultant reviews all submitted documentation and interviews staff using the question patterns used in actual validation reviews. It surfaces gaps when there is still time to correct them and prepares staff to respond accurately under interview conditions.

Organizations that complete thorough mock surveys significantly outperform those that go directly to submission. IHS conducts mock surveys as a standard component of every accreditation engagement.

Does URAC Disease Management Accreditation cover specific disease states or the overall program?

URAC Disease Management Accreditation evaluates the organization's overall program model for managing chronic populations — not individual disease states in isolation. The standards assess how the organization identifies and stratifies its managed population, communicates across conditions, manages risk, and monitors quality outcomes. The credential applies to the disease management approach as a whole, regardless of whether the organization focuses on diabetes, heart disease, COPD, behavioral health, chronic kidney disease, or a multi-condition population.

How does URAC Disease Management Accreditation relate to NCQA Population Health Program Accreditation?

NCQA retired its Disease Management Accreditation and Certification programs in 2019, replacing them with Population Health Program Accreditation — a broader credential reflecting the market shift from single-condition DM toward whole-person population health. URAC continues to maintain active Disease Management Accreditation standards, making it the primary DM-specific third-party credential currently available.

Some organizations pursue both URAC and NCQA credentials for different client segments. IHS advises on the optimal multi-body strategy given your market position and contractual requirements.

Have More Questions? Talk to an IHS Principal.

URAC Disease Management Accreditation is a complex, multi-phase process. The questions above cover common ground, but every organization's situation is different — different baseline readiness, different client requirements, different timelines. IHS provides a free initial consultation to assess your specific circumstances and give you an honest picture of what the path to accreditation looks like for your organization.

Schedule a Free Discovery Session with an IHS principal — led by Thomas G. Goddard, JD, PhD, former Chief Operating Officer and General Counsel of URAC.